<DOC>
	<DOCNO>NCT02286401</DOCNO>
	<brief_summary>The purpose pilot study proposal test ability Transluminal Flow Encoding ( TAFE ) evaluate vessel specific ischemia patient clinical indication invasive coronary angiography ( ICA ) fractional flow reserve ( FFR ) measurement suspect coronary disease .</brief_summary>
	<brief_title>Functional Assessment Coronary Artery Disease CTA Flow Encoding</brief_title>
	<detailed_description>The purpose pilot study test ability Transluminal Flow Encoding ( TAFE ) evaluate vessel specific ischemia patient clinical indication invasive coronary angiography ( ICA ) fractional flow reserve ( FFR ) measurement suspect coronary disease . TAFE novel method derives coronary blood flow easily obtainable non-invasive coronary CT angiogram . Participants undergo rest coronary CTA , regadenoson stress CT , clinically indicate invasive coronary angiogram . The study aim determine accuracy TAFE compare invasive fractional flow reserve . We hypothesize TAFE-derived coronary blood flow , coronary flow reserve , myocardial CT perfusion image accurately diagnose abnormal FFR ( &lt; 0.80 ) measure vessel patient undergo invasive coronary angiography .</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<criteria>Inclusion Criteria A . Male female patient , age 40 year old . Women child bear potential must demonstrate negative pregnancy test within 24 hour study CT. B . Referral invasive coronary angiography suspicion coronary artery disease possible percutaneous intervention plan . C. Able understand willing sign Informed Consent Form . A . Patients known history coronary artery bypass surgery . B . Current previous ST elevation myocardial infarction ( MI ) , prior MI ( confirm persistent pathologic Q wave ECG , clinical report CPKMB Troponin &gt; three time upper limit normal fix perfusion defect nuclear imaging ) C. Current evidence acute myocardial ischemia , unstable angina , cardiovascular instability include troponin &gt; limit detection ( â‰¥0.06 ng/ml ) , new ST depression &gt; 1 mm , hypotension systolic pressure &lt; 90 mm Hg . D. Known allergy iodinate contrast medium E. Known suspect intolerance contraindication betablockers include : 1 . Known allergy betablockers 2 . History moderate severe bronchospastic lung disease ( include moderate severe asthma ) F. Known allergy regadenoson aminophylline . G. Any patient deem medically stable physician . F. Known suspect severe symptomatic aortic stenosis . G. Severe hypertrophic obstructive cardiomyopathy . H. Evidence severe symptomatic heart failure ( NYHA Class III IV ) time scan . I . Inability lie flat . J. Atrial fibrillation uncontrolled tachyarrhythmia , advance atrioventricular block ( second third degree heart block ) K. Elevated serum creatinine ( &gt; 1.5mg/dl ) OR calculate creatinine clearance &lt; 60 ml/min ( use CockcroftGault formula ) L. History contrastinduced nephropathy M. Severe pulmonary disease disorder allow patient hold breath 10 second . N. History organ transplantation O . Acute myocarditis pericarditis . P. Recent history illicit drug use ( past 3 month ) Q . Recent use dipyridamole contain medication . R. Current pregnancy .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>myocardial perfusion</keyword>
	<keyword>coronary atherosclerosis</keyword>
	<keyword>coronary blood flow</keyword>
	<keyword>fractional flow reserve</keyword>
	<keyword>coronary flow reserve</keyword>
</DOC>